Canopy Growth Corporation develops and sells cannabis products for adult-use and medical markets, with common shares trading as CGC on Nasdaq and WEED on the TSX. Company updates frequently cover Canadian brand activity across Tweed, Deelish, 7ACRES, DOJA, Deep Space and related formats including flower, pre-rolls, vapes, softgels and minor cannabinoid products.
News also centers on medical cannabis services through Canada House Clinics and the Abba Medix online channel, Storz & Bickel vaporization devices, operating and financial results, capital-structure actions, shareholder voting matters and governance changes. Canopy Growth also discloses its unconsolidated, non-controlling interest in Canopy USA as exposure to the U.S. THC market.
Canopy Growth Corporation (NYSE: CGC) will host its 2020 Annual General and Special Meeting on September 21, 2020, starting at 10:00 AM ET. The meeting will occur in a virtual format accessible via a live audio webcast. Shareholders of record as of July 28, 2020 are eligible to vote. A notice detailing instructions on how to participate and vote has been mailed to eligible shareholders. Canopy Growth is a leading cannabis company known for its diverse products and significant market presence, including partnerships with notable brands.
Canopy Growth Corporation reported a 22% increase in net revenue to $110.4 million for Q1 FY21 compared to Q1 FY20, despite a net loss of $128.3 million. The Adjusted EBITDA loss narrowed to $92 million. The company strengthened its position in the cannabis-infused beverage market by shipping over 1.2 million cans since launch and expanded its U.S. presence with the launch of shopcanopy.com. Gross margins fell to 6%, affected by lower production output. The company reduced operating expenses by 23% and maintained a strong cash position of $2 billion.
Canopy Growth Corporation (NYSE: CGC) will announce its financial results for the first quarter of fiscal 2021, ending June 30, 2020, on August 10, 2020. A live audio webcast will accompany the announcement at 10:00 AM ET, featuring CEO David Klein and CFO Mike Lee. Investors can access a replay of the webcast until November 8, 2020. Canopy Growth is a leading cannabis company offering various products, including dried cannabis and oils, and is recognized for its commitment to innovation, market execution, and shareholder value.
Canopy Growth Corporation (TSX: WEED, NYSE: CGC) has launched its new U.S. e-commerce website, ShopCanopy.com, which will feature over 25 hemp-derived CBD products. This site aims to provide customers with a convenient shopping experience, showcasing brands like First & Free and BioSteel, along with the upcoming Martha Stewart CBD line. The platform emphasizes transparency, offering Certificates of Analysis for all products to assure quality and safety compliance with state laws and FDA regulations.
Canopy Growth and Acreage Holdings have announced an amended agreement to enhance the original plan of arrangement, facilitating potential upside for shareholders. The new arrangement includes a cash payment of US$37.5 million to Acreage shareholders and introduces two new classes of shares that provide additional upside potential linked to the U.S. cannabis market. The amendments reflect current economic conditions and allow Acreage to raise capital for its hemp operations. A loan of up to US$100 million will support Acreage Hempco, with a total interest rate of 6.1%.
Canopy Rivers welcomes Mike Lee, Chief Financial Officer of Canopy Growth (NYSE: CGC), to its Board of Directors. Lee's extensive experience in financial management from his previous roles will bolster Canopy Rivers' strategic execution in the global cannabis sector. His appointment signifies a deepening relationship with Canopy Growth and Constellation Brands. Canopy Rivers aims to leverage Lee's expertise to enhance its investment strategy and operational oversight, which could positively impact both companies and their portfolios as they navigate the evolving cannabis landscape.